Why is Venmax Drugs falling/rising?

As of 17-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 25.44, reflecting a rise of 1.21 or 4.99%. The stock has shown strong performance, gaining 27.45% over the past week and 5.78% over the last month. It has outperformed its sector by 4.52% today and has been on a consecutive gain streak for the last five days. However, there has been a notable decline in investor participation, with delivery volume dropping by 86.46% against the five-day average, which could indicate a potential concern for future trading activity. The stock's moving averages are higher than the 5-day and 20-day averages but lower than the longer-term averages, suggesting mixed signals regarding its momentum.
Broader market context shows that while Venmax has significantly outperformed the Sensex with a year-to-date return of 41.02% compared to the Sensex's 7.44%, the overall market has been relatively stable with a modest increase of 1.76% over the past week. This strong performance relative to the benchmark indicates that investor sentiment towards Venmax remains positive, despite the recent drop in trading volume. The stock's ability to maintain its price amidst fluctuating investor participation suggests a resilient demand, likely driven by positive market sentiment or company-specific developments.